Published in Immunogenetics on October 30, 2004
Extensive genomic and functional polymorphism of the complement control proteins. Immunogenetics (2005) 0.77
Artemis: sequence visualization and annotation. Bioinformatics (2000) 46.68
MEGA2: molecular evolutionary genetics analysis software. Bioinformatics (2001) 38.50
A dot-matrix program with dynamic threshold control suited for genomic DNA and protein sequence analysis. Gene (1995) 8.45
The regulators of complement activation (RCA) gene cluster. Adv Immunol (1989) 2.63
Disease associations with complotypes, supratypes and haplotypes. Immunol Rev (1983) 1.87
Genomics of the major histocompatibility complex: haplotypes, duplication, retroviruses and disease. Immunol Rev (1999) 1.65
In polymorphic genomic regions indels cluster with nucleotide polymorphism: Quantum Genomics. Gene (2003) 1.33
CR1 and CR1-like: the primate immune adherence receptors. Immunol Rev (2001) 1.27
Functional domains, structural variations and pathogen interactions of MCP, DAF and CR1. Immunopharmacology (2000) 1.25
Extensive nucleotide variability within a 370 kb sequence from the central region of the major histocompatibility complex. Gene (1999) 1.12
Evolutionary relationships among proteins encoded by the regulator of complement activation gene cluster. Mol Biol Evol (2000) 0.99
Genomic organization of a polymorphic duplicated region centromeric of HLA-B. Immunogenetics (1992) 0.89
Complement system proteins which interact with C3b or C4b A superfamily of structurally related proteins. Immunol Today (2014) 0.88
Amino acid patterns within short consensus repeats define conserved duplicons shared by genes of the RCA complex. J Mol Evol (2004) 0.84
Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine. Med Phys (1995) 8.87
Nomenclature for the major histocompatibility complexes of different species: a proposal. Immunogenetics (1990) 3.53
Comparison of API and Minitek to Center for Disease Control methods for the biochemical characterization of anaerobes. J Clin Microbiol (1976) 2.93
Statement on the nomenclature of human C4 allotypes. Immunobiology (1983) 2.66
Mutuality and preparedness as predictors of caregiver role strain. Res Nurs Health (1990) 2.29
Cell-mediated cytotoxicity to muscle in polymyositis. Effect of immunosuppression. N Engl J Med (1973) 2.25
Code of practice for brachytherapy physics: report of the AAPM Radiation Therapy Committee Task Group No. 56. American Association of Physicists in Medicine. Med Phys (1997) 2.05
Derepressed synthesis of cellulase by Cellulomonas. J Bacteriol (1976) 1.94
Disease associations with complotypes, supratypes and haplotypes. Immunol Rev (1983) 1.87
High dose-rate brachytherapy treatment delivery: report of the AAPM Radiation Therapy Committee Task Group No. 59. Med Phys (1998) 1.84
Central MHC genes, IgA deficiency and autoimmune disease. Immunol Today (1990) 1.81
Continuing education for pharmacists and general practitioners. Br J Gen Pract (1991) 1.75
The P5 multicopy gene family in the MHC is related in sequence to human endogenous retroviruses HERV-L and HERV-16. Immunogenetics (1999) 1.71
Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas. J Exp Med (1994) 1.69
Monte Carlo-aided dosimetry of a new high dose-rate brachytherapy source. Med Phys (1998) 1.63
Experimental myositis associated with hypersensitivity to muscle. J Pathol Bacteriol (1965) 1.59
Report of the ad hoc committee of the AAPM radiation therapy committee on 125I sealed source dosimetry. Int J Radiat Oncol Biol Phys (1998) 1.49
Ancestral haplotypes: conserved population MHC haplotypes. Hum Immunol (1992) 1.48
Estimation of tissue volume irradiated by intracavitary implants. Int J Radiat Oncol Biol Phys (1993) 1.40
Polymorphic MHC ancestral haplotypes affect the activity of tumour necrosis factor-alpha. Clin Exp Immunol (1993) 1.39
Experimental autoallergic myositis, polymyositis and myasthenia gravis. Autoimmune muscle disease associated with immunodeficiency and neoplasia. Clin Exp Immunol (1975) 1.38
High dose ratio (HDR) cervical ring applicator to control bleeding from cervical carcinoma. Int J Gynecol Cancer (2002) 1.38
Laboratory tests in clinical immunology: a critique. Am J Med (1980) 1.34
Autoimmunity in ocular and generalised myasthenia gravis. J Neuroimmunol (1981) 1.32
An approach to the localization of the susceptibility genes for generalized myasthenia gravis by mapping recombinant ancestral haplotypes. Immunogenetics (1992) 1.32
The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nat Med (1995) 1.29
Antibodies to skeletal muscle demonstrated by immunofluorescence in experimental autoallergic myositis. Clin Exp Immunol (1971) 1.28
Characterization of mutations in divIB of Bacillus subtilis and cellular localization of the DivIB protein. Mol Microbiol (1993) 1.24
Complement allotyping in SLE: association with C4A null. Aust N Z J Med (1983) 1.24
SNP profile within the human major histocompatibility complex reveals an extreme and interrupted level of nucleotide diversity. Genome Res (2000) 1.24
Rearrangement of 21-hydroxylase genes in disease-associated MHC supratypes. Immunogenetics (1986) 1.23
Genetic control of suppressor lymphocyte function in myasthenia gravis: relationship of impaired suppressor function to HLA-B8/DRW3 and cold reactive lymphocytotoxic antibodies. Clin Immunol Immunopathol (1979) 1.23
A survey of hemoglobin values in Canada. Can Med Assoc J (1970) 1.23
pH and concentrations of pepsin and trypsin in feeding tube aspirates as predictors of tube placement. JPEN J Parenter Enteral Nutr (1998) 1.23
Observer variation in grading sacroiliac radiographs in HLA-B27 positive individuals. J Rheumatol (1983) 1.23
Zidovudine-induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV-infected patients. AIDS (1992) 1.20
Living with a person who has Parkinson's disease: the spouse's perspective by stage of disease. Parkinson's Study Group. Mov Disord (1998) 1.20
HLA and complement allotypes in Type 1 (insulin-dependent) diabetes. Diabetologia (1983) 1.20
Human natural killer (NK) alloreactivity and its association with the major histocompatibility complex: ancestral haplotypes encode particular NK-defined haplotypes. J Exp Med (1993) 1.18
Immune function in ankylosing spondylitis: apparent relationship between streptococcal responses and HLA B27. J Rheumatol Suppl (1977) 1.17
Deblurring subject to nonnegativity constraints when known functions are present with application to object-constrained computerized tomography. IEEE Trans Med Imaging (2001) 1.14
Rapid radiometric method for detection of Salmonella in foods. Appl Environ Microbiol (1980) 1.13
Extensive nucleotide variability within a 370 kb sequence from the central region of the major histocompatibility complex. Gene (1999) 1.12
Ancestral haplotypes reveal the role of the central MHC in the immunogenetics of IDDM. Immunogenetics (1992) 1.11
An analysis of variation in the long-range genomic organization of the human major histocompatibility complex class II region by pulsed-field gel electrophoresis. Genomics (1989) 1.11
Cancer in connective tissue disease. Arthritis Rheum (1982) 1.11
Exposure to blood borne infections in health care workers. Med J Aust (1992) 1.10
Development of a reliable and valid bedside test for bilirubin and its utility for improving prediction of feeding tube location. Nurs Res (2000) 1.09
Cervical tumor control evaluated with ICRU 38 reference volumes and integrated reference air kerma. Radiother Oncol (2001) 1.09
ICMSF methods studies. XIII. An international comparative study of the MPN procedure and the Anderson-Baird-Parker direct plating method for the enumeration of Escherichia coli biotype I in raw meats. Can J Microbiol (1979) 1.08
Use of the B27 test in the diagnosis of ankylosing spondylitis: a statistical evaluation. Arthritis Rheum (1981) 1.08
A new polymorphic and multicopy MHC gene family related to nonmammalian class I. Immunogenetics (1994) 1.07
Family studies of IgA deficiency. Immunogenetics (1985) 1.07
Hepatocellular carcinoma: presentation with vertebral metastases and radicular compression. Cancer (1972) 1.07
The PREP system of nursing interventions: a pilot test with families caring for older members. Preparedness (PR), enrichment (E) and predictability (P). Res Nurs Health (1995) 1.06
The diagnostic significance of autoantibodies to the acetylcholine receptor. J Neuroimmunol (1982) 1.05
Diagnostic significance of thyroid microsomal antibodies in randomly selected population. Lancet (1980) 1.05
HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis. Br Med J (Clin Res Ed) (1983) 1.04
Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies. J Immunol Methods (1988) 1.04
Family caregiving skill: development of the concept. Res Nurs Health (2000) 1.04
Quantitative evaluation of radiochromic film response for two-dimensional dosimetry. Med Phys (1997) 1.04
Sense of coherence as a predictor of quality of life in persons with coronary heart disease surviving cardiac arrest. Res Nurs Health (1996) 1.03
Resin-process methods for improved isolation of organisms from blood and other body fluids. Am J Med (1983) 1.00
Autoantibodies and HLA antigens in ocular, generalized and penicillamine-induced myasthenia gravis. Ann N Y Acad Sci (1981) 0.99
Monte Carlo evaluation of kerma at a point for photon transport problems. Med Phys (1987) 0.99
Major histocompatibility complex genes influence the outcome of HIV infection. Ancestral haplotypes with C4 null alleles explain diverse HLA associations. Hum Immunol (1990) 0.99
Extensive deletions and insertions in different MHC supratypes detected by pusled field gel electrophoresis. J Exp Med (1988) 0.99
Different evolutionary histories in two subgenomic regions of the major histocompatibility complex. Genome Res (1999) 0.99
Clinical trial to compare tinnitus masking and tinnitus retraining therapy. Acta Otolaryngol Suppl (2006) 0.99
Cross-reactivity of anti-acetylcholine receptor autoantibodies. Muscle Nerve (1981) 0.98
pH and concentration of bilirubin in feeding tube aspirates as predictors of tube placement. Nurs Res (1999) 0.98
Immune function in ankylosing spondylitics and their relatives: influence of disease and HLA B27. Clin Exp Immunol (1978) 0.98
Penicillamine-associated myasthenia gravis, antiacetylcholine receptor and antistriational antibodies. Am J Med (1977) 0.98
Loss of HLA class I expression in prostate cancer: implications for immunotherapy. Urology (1995) 0.97
Characterisation of immunofluorescent heterophile antibodies which may be confused with autoantibodies. J Clin Pathol (1977) 0.97
TLD, diode and Monte Carlo dosimetry of an 192Ir source for high dose-rate brachytherapy. Phys Med Biol (1995) 0.96
Reference ranges for serum C4 concentrations in subjects with and without C4 null alleles. J Clin Pathol (1986) 0.96
Validation of a precision radiochromic film dosimetry system for quantitative two-dimensional imaging of acute exposure dose distributions. Med Phys (2000) 0.96
Differences in gene copy number carried by different MHC ancestral haplotypes. Quantitation after physical separation of haplotypes by pulsed field gel electrophoresis. J Exp Med (1990) 0.96
Positive allergy prick tests associated with bronchial histamine responsiveness in an unselected population. J Allergy Clin Immunol (1986) 0.96
Epidemiology of late presentation of HIV infection in Western Australia. Med J Aust (1992) 0.95
Direct observation of the gene organization of the complement C4 and 21-hydroxylase loci by pulsed field gel electrophoresis. J Exp Med (1989) 0.95
Infant botulism. Med J Aust (1980) 0.95
The implications of intergenic polymorphism for major histocompatibility complex evolution. Genetics (2000) 0.95
Coevolution of PERB11 (MIC) and HLA class I genes with HERV-16 and retroelements by extended genomic duplication. J Mol Evol (1999) 0.95
HLA in systemic lupus erythematosus: influence on severity. Tissue Antigens (1978) 0.94
Anatomic variation of gynecologic brachytherapy prescription points. Int J Radiat Oncol Biol Phys (1993) 0.94
Cytotoxic effect of antisera on 51Cr-labelled monolayers of skeletal muscle. J Pathol (1973) 0.93
The major histocompatability complex (MHC) contains conserved polymorphic genomic sequences that are shuffled by recombination to form ethnic-specific haplotypes. J Mol Evol (1997) 0.93
Angioimmunoblastic lymphadenopathy with dysproteinemia. Cancer (1977) 0.93
Letter: Penicillamine therapy, antistriational antibody, and myasthenia gravis. Br Med J (1975) 0.92
Susceptibility to IDDM is marked by MHC supratypes rather than individual alleles. Immunogenetics (1985) 0.92
Myogenesis in vitro as demonstrated by immunofluorescent staining with antimuscle serum. Exp Cell Res (1971) 0.92
Ovarian function after successful bone marrow transplantation in postmenarcheal females. Med Pediatr Oncol (1983) 0.92
Major histocompatibility complex (MHC) complement deficiency, ancestral haplotypes and systemic lupus erythematosus (SLE): C4 deficiency explains some but not all of the influence of the MHC. J Rheumatol (1991) 0.92
Respiratory regularity gated 4D CT acquisition: concepts and proof of principle. Australas Phys Eng Sci Med (2007) 0.92
Vacuolar myopathy associated with chloroquine, lupus erythematosus and thymoma. Report of a case with unusual mitochondrial changes and lipid accumulation in muscle. J Neurol Sci (1977) 0.91
Quantitative optical densitometry with scanning-laser film digitizers. Med Phys (1999) 0.91
Conceptualization and measurement of doing family caregiving well. Image J Nurs Sch (1998) 0.90
Monte Carlo-aided dosimetry of the Source Tech Medical Model STM1251 I-125 interstitial brachytherapy source. Med Phys (2001) 0.90